Yoles E - Search Results

1

Beneficial effect of orally administered myelin basic protein in EAE-susceptible Lewis rats in a model of acute CNS degeneration.

Monsonego A, Beserman ZP, Kipnis J, Yoles E, Weiner HL, Schwartz M. Monsonego A, et al. Among authors: yoles e. J Autoimmun. 2003 Sep;21(2):131-8. doi: 10.1016/s0896-8411(03)00091-x. J Autoimmun. 2003. PMID: 12935782

2

Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent.

Bakalash S, Kipnis J, Yoles E, Schwartz M. Bakalash S, et al. Among authors: yoles e. Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2648-53. Invest Ophthalmol Vis Sci. 2002. PMID: 12147598

3

Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity.

Kipnis J, Mizrahi T, Yoles E, Ben-Nun A, Schwartz M. Kipnis J, et al. Among authors: yoles e. J Neuroimmunol. 2002 Sep;130(1-2):78-85. doi: 10.1016/s0165-5728(02)00219-9. J Neuroimmunol. 2002. PMID: 12225890

4

Therapeutic vaccination for closed head injury.

Kipnis J, Nevo U, Panikashvili D, Alexandrovich A, Yoles E, Akselrod S, Shohami E, Schwartz M. Kipnis J, et al. Among authors: yoles e. J Neurotrauma. 2003 Jun;20(6):559-69. doi: 10.1089/089771503767168483. J Neurotrauma. 2003. PMID: 12906740

5

Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury.

Hauben E, Gothilf A, Cohen A, Butovsky O, Nevo U, Smirnov I, Yoles E, Akselrod S, Schwartz M. Hauben E, et al. Among authors: yoles e. J Neurosci. 2003 Sep 24;23(25):8808-19. doi: 10.1523/JNEUROSCI.23-25-08808.2003. J Neurosci. 2003. PMID: 14507981 Free PMC article.

6

Immune-based therapy for spinal cord repair: autologous macrophages and beyond.

Schwartz M, Yoles E. Schwartz M, et al. Among authors: yoles e. J Neurotrauma. 2006 Mar-Apr;23(3-4):360-70. doi: 10.1089/neu.2006.23.360. J Neurotrauma. 2006. PMID: 16629622 Review.

7

A novel immune-based therapy for stroke induces neuroprotection and supports neurogenesis.

Ziv Y, Finkelstein A, Geffen Y, Kipnis J, Smirnov I, Shpilman S, Vertkin I, Kimron M, Lange A, Hecht T, Reyman KG, Marder JB, Schwartz M, Yoles E. Ziv Y, et al. Among authors: yoles e. Stroke. 2007 Feb;38(2 Suppl):774-82. doi: 10.1161/01.STR.0000255784.27298.23. Stroke. 2007. PMID: 17261737

8

NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush.

Yoles E, Muller S, Schwartz M. Yoles E, et al. J Neurotrauma. 1997 Sep;14(9):665-75. doi: 10.1089/neu.1997.14.665. J Neurotrauma. 1997. PMID: 9337128

9

Potential neuroprotective therapy for glaucomatous optic neuropathy.

Yoles E, Schwartz M. Yoles E, et al. Surv Ophthalmol. 1998 Jan-Feb;42(4):367-72. doi: 10.1016/s0039-6257(97)00123-9. Surv Ophthalmol. 1998. PMID: 9493279 Review.

10

Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve.

Yoles E, Schwartz M. Yoles E, et al. Arch Ophthalmol. 1998 Jul;116(7):906-10. doi: 10.1001/archopht.116.7.906. Arch Ophthalmol. 1998. PMID: 9682704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters